Guidelines on the use of extracorporeal photopheresis

BACKGROUND: After the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma was published in 1983 with its subsequent recognition by the FDA for its refractory forms, the technology has shown significant promise in the treatment of othe...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Eur Acad Dermatol Venereol
मुख्य लेखकों: Knobler, R, Berlin, G, Calzavara-Pinton, P, Greinix, H, Jaksch, P, Laroche, L, Ludvigsson, J, Quaglino, P, Reinisch, W, Scarisbrick, J, Schwarz, T, Wolf, P, Arenberger, P, Assaf, C, Bagot, M, Barr, M, Bohbot, A, Bruckner-Tuderman, L, Dreno, B, Enk, A, French, L, Gniadecki, R, Gollnick, H, Hertl, M, Jantschitsch, C, Jung, A, Just, U, Klemke, C-D, Lippert, U, Luger, T, Papadavid, E, Pehamberger, H, Ranki, A, Stadler, R, Sterry, W, Wolf, IH, Worm, M, Zic, J, Zouboulis, CC, Hillen, U
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BlackWell Publishing Ltd 2014
विषय:
Guidelines on the Use of Extracorporeal Photopheresis. Publication of This Supplement was Supported by a Grant From the European Dermatology Forum
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4291097/
https://ncbi.nlm.nih.gov/pubmed/24354653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.12311
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन